Market Cap | ₹7,143Cr |
ROE | 3.77% |
P/E Ratio(TTM) | 64.30 |
EPS(TTM) | 5.68 |
P/B Ratio | 3.01 |
Dividend Yield | 0.14% |
Industry P/E | 35.07 |
Book Value | 121.29 |
Debt to Equity | 0.25 |
Face Value | 1 |
Parent Organisation | Shilpa Medicare Limited |
Managing Director | Mr. Vishnukant Bhutada |
NSE Symbol | SHILPAMED |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 59.50 | ||
Gland Pharma | NA (0.00%) | 41.26 | ||
Ajanta Pharma | NA (0.00%) | 32.48 | ||
Eris Lifesciences | NA (0.00%) | 53.35 |